Our building division will soon begin work on the construction of a new £3.5million cyclotron facility for Alliance Medical.
A cyclotron is used in the medical world to accelerate ions at high frequency and alternating voltage to create short lived radioactive isotopes used for diagnostic imaging in Positron Emission Tomography (PET). This project will allow its client to substantially increase its capacity for PET products whilst also adding a new capability of manufacture of products for Single-Photon Emission Computed Tomography (SPECT).
Howard Marsh, Alliance Medical’s Managing Director – Radiopharmacy, had this to say about the construction project:
“We are delighted to be working with North Midland Construction PLC in re-commissioning and expanding our Dinnington facility, bringing the total number of cyclotrons in our network to six. The addition of a new higher energy cyclotron has capability to produce both PET/CT and SPECT products, which, along with the significant additional PET production capacity, will give surety of supply to our patients and customers in sourcing radioactive tracers from Alliance Medical.”
The project, which is due to take 40 weeks to complete, will begin with the construction of a steel frame extension to an existing facility to create an appropriate space for the new cyclotron with a new larger bunker required to house it. This is partly underground with walls 2.5 metres thick, due to the radiation generated when the equipment is in use.
Nick Banks, Operations Director for the building division, said:
“We are delighted to be handling this project for Alliance Medical. It is the first time that we have worked with this client. Whilst we will be handling the construction of the new facility ourselves, due to the complexity and nature of this piece of equipment, we will also be working with a number of specialist companies to install the cyclotron, manufacturing and processing equipment.
“The new cyclotron facility will be an extremely valuable addition to Alliance Medical and the combination of additional capacity and new products will be warmly received by hospitals across the UK.“